Recent Advancements in Liposome-Based Strategies for Effective Drug Delivery to the Brain

Author(s): Parvin Zamani, Peter E. Penson, George E. Barreto, Amirhossein Sahebkar*

Journal Name: Current Medicinal Chemistry

Volume 28 , Issue 21 , 2021

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Disorders of the central nervous system (CNS) and tumors of the brain are challenging to treat, and they rank amongst the most common causes of death worldwide. The delivery of drugs to the brain is problematic because the blood-brain barrier (BBB) effectively arrests the transport of large molecules (including drugs) from the blood to the CNS. Nanoparticle (NP)-mediated drug delivery has received much interest as a technique to overcome this difficulty. In particular, liposome NPs are promising candidates to carry and deliver drugs across the BBB and into the CNS. Liposomes are easy to prepare, highly biodegradable, and biocompatible. Liposomes can be easily modified with various ligands to enable efficient and targeted drug delivery. Liposomes can promote increased cellular uptake of drugs and can reduce the extent to which efflux transporters can remove drugs. Liposomes can be loaded with a wide range of drugs and biologically active substances. In this review, we will summarize recent advances in research relating to liposome-based strategies to enable drug delivery across the BBB.

Keywords: Blood-brain barrier, drug targeting, dual ligand-modified liposomes, transferrin, cell-penetrating peptide, central nervous system.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 18 December, 2020
Page: [4152 - 4171]
Pages: 20
DOI: 10.2174/0929867328666201218121728
Price: $65

Article Metrics

PDF: 255